Annalisa Iezzi

2.3k total citations
19 papers, 1.8k citations indexed

About

Annalisa Iezzi is a scholar working on Pharmacology, Cardiology and Cardiovascular Medicine and Cancer Research. According to data from OpenAlex, Annalisa Iezzi has authored 19 papers receiving a total of 1.8k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pharmacology, 6 papers in Cardiology and Cardiovascular Medicine and 6 papers in Cancer Research. Recurrent topics in Annalisa Iezzi's work include Protease and Inhibitor Mechanisms (6 papers), Inflammatory mediators and NSAID effects (6 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). Annalisa Iezzi is often cited by papers focused on Protease and Inhibitor Mechanisms (6 papers), Inflammatory mediators and NSAID effects (6 papers) and Antiplatelet Therapy and Cardiovascular Diseases (5 papers). Annalisa Iezzi collaborates with scholars based in Italy, United States and Canada. Annalisa Iezzi's co-authors include Andrea Mezzetti, Francesco Cipollone, Franco Cuccurullo, Maria Fazia, Barbara Pini, Francesco Chiarelli, Domenico De Cesare, S Ucchino, Chiara Cuccurullo and Francesco Spigonardo and has published in prestigious journals such as Circulation, Gastroenterology and Diabetes Care.

In The Last Decade

Annalisa Iezzi

19 papers receiving 1.8k citations

Peers

Countries citing papers authored by Annalisa Iezzi

Since Specialization

Citations

This map shows the geographic impact of Annalisa Iezzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Annalisa Iezzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Annalisa Iezzi more than expected).

Fields of papers citing papers by Annalisa Iezzi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Annalisa Iezzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Annalisa Iezzi. The network helps show where Annalisa Iezzi may publish in the future.

Co-authorship network of co-authors of Annalisa Iezzi

This figure shows the co-authorship network connecting the top 25 collaborators of Annalisa Iezzi. A scholar is included among the top collaborators of Annalisa Iezzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Annalisa Iezzi. Annalisa Iezzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	4CPS-092 Analysis of antibiotics consumption at an Italian cardiology centre: pharmacouse profile according to the aware classification 2024 ·Section 4: Clinical pharmacy services ·Annalisa Iezzi, (unknown), Massimo Cella, (unknown), (unknown), (unknown), Emanuela Omodeo Salè	1
2	Agreement of site and central readings of ileocolonoscopic scores in Crohn's disease: comparison using data from the EXTEND trial 2015 ·Gastrointestinal Endoscopy ·Paul Rutgeerts, Walter Reinisch, Jean‐Frédéric Colombel, William J. Sandborn, Geert D’Haens, Joel Petersson, Qian Zhou, Annalisa Iezzi, Roopal Thakkar	22
3	Characterization of Mucosal Healing With Adalimumab Treatment in Patients With Moderately to Severely Active Crohn’s Disease From EXTEND 2014 ·The American Journal of Gastroenterology ·Walter Reinisch, Jean–Frédéric Colombel, Geert D’Haens, William J. Sandborn, Paul Rutgeerts, Joel Petersson, Samantha Eichner, Qian Zhou, Annalisa Iezzi, Roopal Thakkar	1
4	Mo1219 Adalimumab Achieves Efficacy in Mucosal Healing Regardless of Baseline Disease Severity in Patients With Crohn's Disease: Data From EXTEND 2014 ·Gastroenterology ·William J. Sandborn, Douglas C. Wolf, Jean–Frédéric Colombel, Julián Panés, Samantha Eichner, Annalisa Iezzi, Qian Zhou, Anne Robinson, (unknown), Roopal Thakkar	1
5	P572 Adalimumab achieves efficacy in mucosal healing regardless of baseline disease severity in patients with Crohn's disease: Data from EXTEND 2014 ·Journal of Crohn s and Colitis ·William J. Sandborn, Douglas C. Wolf, (unknown), Julián Panés, Samantha Eichner, Annalisa Iezzi, Qian Zhou, A. M. Robinson, (unknown), (unknown)	1
6	COX-2: Friend or Foe? 2007 ·Current Pharmaceutical Design ·Annalisa Iezzi, Claudio Ferri, Andrea Mezzetti, Francesco Cipollone	35
7	Suppression of Rage as a Basis of Simvastatin-Dependent Plaque Stabilization in Type 2 Diabetes 2006 ·Arteriosclerosis Thrombosis and Vascular Biology ·Chiara Cuccurullo, Annalisa Iezzi, Maria Fazia, Domenico De Cesare, Andrea Di Francesco, Raffaella Muraro, Roberto Bei, S Ucchino, Francesco Spigonardo, Francesco Chiarelli, Ann Marie Schmidt, Franco Cuccurullo, Andrea Mezzetti, Francesco Cipollone	129
8	Enhanced soluble CD40 ligand contributes to endothelial cell dysfunction in vitro and monocyte activation in patients with diabetes mellitus: effect of improved metabolic control 2005 ·Diabetologia ·Francesco Cipollone, Francesco Chiarelli, Giovanni Davı̀, Claudio Ferri, Giovambattista Desideri, (unknown), Annalisa Iezzi, Francesca Santilli, Barbara Pini, C. Cuccurullo, Stefano Tumini, A Del Ponte, Annalisa Santucci, Franco Cuccurullo, Andrea Mezzetti	85
9	Association Between Prostaglandin E Receptor Subtype EP4 Overexpression and Unstable Phenotype in Atherosclerotic Plaques in Human 2005 ·Arteriosclerosis Thrombosis and Vascular Biology ·Francesco Cipollone, Maria Fazia, Annalisa Iezzi, Chiara Cuccurullo, Domenico De Cesare, S Ucchino, Francesco Spigonardo, Antonio Marchetti, Fiamma Buttitta, Leonardo Paloscia, (unknown), Franco Cuccurullo, Andrea Mezzetti	82
10	Association Between 5-Lipoxygenase Expression and Plaque Instability in Humans 2005 ·Arteriosclerosis Thrombosis and Vascular Biology ·Francesco Cipollone, Andrea Mezzetti, Maria Fazia, Chiara Cuccurullo, Annalisa Iezzi, S Ucchino, Francesco Spigonardo, Marco Bucci, Franco Cuccurullo, Stephen M. Prescott, Diana M. Stafforini	140
11	Relationship between Reduced BCL-2 Expression in Circulating Mononuclear Cells and Early Nephropathy in Type 1 Diabetes 2005 ·International Journal of Immunopathology and Pharmacology ·Francesco Cipollone, Francesco Chiarelli, Annalisa Iezzi, Maria Fazia, C. Cuccurullo, Barbara Pini, Domenico De Cesare, Monica Torello, Stefano Tumini, Franco Cuccurullo, Andrea Mezzetti	21
12	Increased Expression of Transforming Growth Factor-β1 as a Stabilizing Factor in Human Atherosclerotic Plaques 2004 ·Stroke ·Francesco Cipollone, Maria Fazia, Gabriella Mincione, Annalisa Iezzi, Barbara Pini, Chiara Cuccurullo, S Ucchino, Francesco Spigonardo, Marcello Di Nisio, Franco Cuccurullo, Andrea Mezzetti, Ettore Porreca	84
13	Blockade of the Angiotensin II Type 1 Receptor Stabilizes Atherosclerotic Plaques in Humans by Inhibiting Prostaglandin E ₂ –Dependent Matrix Metalloproteinase Activity 2004 ·Circulation ·Francesco Cipollone, Maria Fazia, Annalisa Iezzi, Barbara Pini, Chiara Cuccurullo, Mirco Zucchelli, Domenico De Cesare, S Ucchino, Francesco Spigonardo, (unknown), Raffaella Muraro, Roberto Bei, Marco Bucci, Franco Cuccurullo, Andrea Mezzetti	123
14	Suppression of the Functionally Coupled Cyclooxygenase-2/Prostaglandin E Synthase as a Basis of Simvastatin-Dependent Plaque Stabilization in Humans 2003 ·Circulation ·Francesco Cipollone, Maria Fazia, Annalisa Iezzi, (unknown), Barbara Pini, Domenico De Cesare, S Ucchino, Francesco Spigonardo, (unknown), Roberto Bei, Raffaella Muraro, Luciano Artese, Adriano Piattelli, Francesco Chiarelli, Franco Cuccurullo, Andrea Mezzetti	120
15	Preprocedural Level of Soluble CD40L Is Predictive of Enhanced Inflammatory Response and Restenosis After Coronary Angioplasty 2003 ·Circulation ·Francesco Cipollone, Claudio Ferri, Giovambattista Desideri, Leonardo Paloscia, Guido Materazzo, (unknown), Maria Fazia, Annalisa Iezzi, Chiara Cuccurullo, Barbara Pini, Marco Bucci, Anna Santucci, Franco Cuccurullo, Andrea Mezzetti	96
16	The Receptor RAGE as a Progression Factor Amplifying Arachidonate-Dependent Inflammatory and Proteolytic Response in Human Atherosclerotic Plaques 2003 ·Circulation ·Francesco Cipollone, Annalisa Iezzi, Maria Fazia, Mirco Zucchelli, Barbara Pini, Chiara Cuccurullo, Domenico De Cesare, Giovanni De Blasis, Raffaella Muraro, Roberto Bei, Francesco Chiarelli, Ann Marie Schmidt, Franco Cuccurullo, Andrea Mezzetti	324
17	Circulating Monocyte Chemoattractant Protein-1 and Early Development of Nephropathy in Type 1 Diabetes 2002 ·Diabetes Care ·Francesco Chiarelli, Francesco Cipollone, Angelika Mohn, Matteo Marini, Annalisa Iezzi, Maria Fazia, Stefano Tumini, Domenico De Cesare, Mariapina Pomilio, Sante D. Pierdomenico, Mario Di Gioacchino, Franco Cuccurullo, Andrea Mezzetti	70
18	Elevated Circulating Levels of Monocyte Chemoattractant Protein-1 in Patients With Restenosis After Coronary Angioplasty 2001 ·Arteriosclerosis Thrombosis and Vascular Biology ·Francesco Cipollone, Matteo Marini, Maria Fazia, Barbara Pini, Annalisa Iezzi, Marcella Reale, Leonardo Paloscia, Guido Materazzo, E D'Annunzio, Pio Conti, Francesco Chiarelli, Franco Cuccurullo, Andrea Mezzetti	177
19	Overexpression of Functionally Coupled Cyclooxygenase-2 and Prostaglandin E Synthase in Symptomatic Atherosclerotic Plaques as a Basis of Prostaglandin E ₂ -Dependent Plaque Instability 2001 ·Circulation ·Francesco Cipollone, Cesaria Prontera, Barbara Pini, Matteo Marini, Maria Fazia, Domenico De Cesare, Annalisa Iezzi, S Ucchino, Gianfranco Boccoli, Vittorio Saba, Francesco Chiarelli, Franco Cuccurullo, Andrea Mezzetti	315

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact